The results revealed that sitagliptin could attenuate obesity-induced hepatic insulin resistance and steatosis, suppress inflammation by regulating macrophage M1/M2 polarization imbalance, and promote liver autophagy via AMPK/mTOR signaling pathway. The gene discussed is MTOR; the disease is Obesity.